Acadia Healthcare Company Inc. announced its financial results for the first quarter of 2025, revealing a revenue increase to $770.5 million from $768.1 million in the same period of 2024. The company reported a net income attributable to Acadia of $8.4 million, equivalent to $0.09 per diluted share. Additionally, the adjusted income attributable to Acadia was $36.9 million, or $0.40 per diluted share. Same facility revenue grew by 2.1% compared to the first quarter of 2024, driven by a 2.2% increase in patient days, although both metrics were slightly impacted negatively by the leap year effect of about 1.1%. Significant operational progress included the addition of 378 newly licensed beds during the quarter, comprising 90 beds in existing facilities and 288 from newly built facilities. The company remains focused on expanding access to care and treatment for underserved patient populations with complex needs. Acadia Healthcare continues to expect a net increase in Medicaid supplemental payments ranging from $0 to $15 million for the full year 2025, incorporating the new Tennessee program. The company's guidance excludes potential impacts from future acquisitions, divestitures, and certain non-recurring expenses.